Skip to content

Picosecond Laser combined with a Cream Formulation Containing Levorotatory Vitamin C 10% and Arbutin 4% for Treatment of Melasma

Picosecond Laser combined with a Cream Formulation Containing Levorotatory Vitamin C 10% and Arbutin 4% for Treatment of Melasma

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042939
Enrollment
Unknown
Registered
2021-02-01
Start date
2021-02-08
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

melasma

Interventions

experimental group:755nm picosecond laser combined with a cream formulation containing levorotatory vitamin C and arbutin

Sponsors

Beijing Friendship Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed melasma according to the criteria for diagnosis and treatment of melasma and vitiligo; 2. Aged 18~60 years, male or female; 3. Patients in stable condition in the last three months; 4. Voluntarily sign the informed consent form; 5. Patients who have good compliance, and can regularly participate in follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients who have received treatment in the last six months, including systematic medication, topical medication, chemical peeling,photoelectric therapy, mesodermal therapy or other whitening treatments; 2. Outdoor workers with a history of exposure or long exposure to sunlight in the last three months; 3. Patients in pregnancy, lactation or preparation for pregnancy; 4. Patients with severe systemic diseases of heart, brain, liver, kidney, blood or others,or immune deficiency; 5. Patients with any facial skin disease or other pigmented disease affecting the diagnosis of melasma; 6. Light sensitive or allergic to anesthetic; 7. Patients who can not avoid light after laser.

Design outcomes

Primary

MeasureTime frame
MASI;

Secondary

MeasureTime frame
PGA;MelasQoL;

Countries

China

Contacts

Public ContactYang Gaoyun

Beijing Friendship Hospital Affiliated to Capital Medical University

gaoyun668@aliyun.com+86 13520713158

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026